The Enactus World Cup showcases college and university students around the world who go above and beyond to help their communities through entrepreneurial action. This year the event will be held in Beijing, China from 22-24 October and select events will be livestreamed.
Most TB drugs currently approved for treatment are 50+ years old and are required to be taken over a 6-month period to be effective. Compliance with such a long treatment regimen is a challenge, limiting drugs’ effectiveness and contributing to the rise in MDR-TB. As part of its MDR-TB Partnership, Eli Lilly and Company formed innovative partnerships with the Infectious Disease Research Institute (IDRI) and the Bill and Melinda Gates Foundation to discover new and more effective TB drugs.
Results of Japanese Study Published in the Journal of Dairy Science®
Press Release
Philadelphia, PA, October 14, 2014 /3BL Media/ – There has been much interest in the potential for using probiotic bacteria for treating skin diseases and other disorders. Japanese researchers have now found that milk that has been fermented using a probiotic dairy starter can also benefit the skin of young healthy women, reports the Journal of Dairy Science®.
Probiotics have been defined by the Food and Agriculture Organization-World Health Organization as “live microorganisms which, when administered in adequate amounts, confer a health benefit to the host.”
Philadelphia, PA, October 14, 2014 /3BL Media/ – Over the past decades, we have seen numerous tragic examples where the failure of institutions to meet the needs of infants for social contact and stimulation has led to the failure of these infants to thrive.
See how one of our employees lost over 100 pounds.
Multimedia with summary
Safeway associate Marcus Phillips of our Mountain View Store on San Antonio Road in California shares his remarkable journey of losing more than 100 pounds by making just one simple change. Learn more about his inspiring story by watching the video.
Today’s guest post is authored by Timothy J. Garnett, M.D., Senior Vice President, Development Center of Excellence, Lilly Research Laboratories and Chief Medical Officer.
Potential Biomarkers may pave way to a more sensitive, specific, and noninvasive prostate cancer screening assay, according to Report in The Journal of Molecular Diagnostics
Press Release
Philadelphia, PA, October 13, 2014 /3BL Media/ – Researchers at Sanford-Burnham Medical Research Institute have identified a set of RNA molecules that are detectable in tissue samples and urine of prostate cancer patients but not in normal healthy individuals. The study sets the stage for the development of more sensitive and specific noninvasive tests for prostate cancer than those currently available, which could result in fewer unnecessary prostate biopsies with less treatment-related morbidity, according to a new study in The Journal of Molecular Diagnostics.
After spending about 18 months with their puppy raisers and another 6-8 months in advanced training with our professional trainers, SSD Cobalt, SSD Kingston, SSD London, and SSD Outback are ready to work. These four dogs have been working with their new partners in Team Training since Monday.
October 10, 2014 /3BL Media/ - A special event will be held to celebrate EmblemHealth’s support of Children’s Health Fund’s mobile medical program. Through CBS EcoMedia’s WellnessAd program, EmblemHealth will provide health care services to 250 medically underserved children in Harlem and Queens. EmblemHealth’s support will result in approximately 450 health care visits over the next year.
Education is vitally important to our future at Lilly. Today’s student could be tomorrow’s scientist or doctor, which makes our involvement with the IPS Business Alliance so significant.
